-
E-mail
cw@avt-cn.com
-
Phone
15692161719
-
Address
Building A, 27th Floor, 838 Zhangyang Road, Pudong New Area, Shanghai
Avito (Shanghai) Pharmaceutical Technology Co., Ltd
Good news from Avito! Xita Ammonium Chloride has successfully passed the Swiss Swissmedic associated review, and its product strength has once again gained international recognition!
Date: 2025-09-19Read: 0
Recently, Cetalkonium Chloride, independently developed and produced by Avito, has successfully passed the associated review by the Swiss Medicines Agency (Swissmedic) and officially become one of the important active ingredients in the formulation products of a Swiss company. This breakthrough marks the recognition of the Swiss drug regulatory agency for the quality and compliance of Avito Sitamic Chloride, and once again confirms the company's deep accumulation and registration capabilities in the field of injectable excipients.
Xita ammonium chloride is a cationic quaternary ammonium salt surfactant and one of the components of benzalkonium chloride. It has the characteristics of high lipophilicity and low water solubility, and is widely used in fields such as anti infective agents, surfactants, and pharmaceutical excipients.
As a pharmaceutical enterprise that has been deeply engaged in the field of functional excipients for injection for nearly 20 years, Aiweituo has always taken products as the core to build a global quality excipient library covering the trinity of "self research+commission+agency". Now, it has launched more than 100 key excipients. The product line depth meets the core needs of eight categories of preparations, including fat emulsion, liposomes, nucleic acid drugs/LNP, biological products, injectable medicine, vaccine adjuvants, in situ gel, nasal spray preparations, etc.
In terms of registration, the company continues to adopt a dual track industry layout:
Domestically: 54 auxiliary material varieties have been registered in CDE, of which 18 varieties have obtained "A" status (related review approved);
International: 30 products have been registered in DMF with the US FDA, providing solid support for pharmaceutical companies to go global.
The obtaining of Swiss license for Xitai ammonium chloride not only reflects our company's ability in international registration and application, but also further strengthens the trusted partner image of Avito in the global excipient market.
In the future, we will continue to uphold the concept of "strengthening the pharmaceutical foundation with excipients", continuously provide customers with compliant, stable, and high-performance excipient products, help innovative formulations land, and empower Chinese medicine to go global.
